Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation
- 1 December 1984
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 91 (12) , 1216-1223
- https://doi.org/10.1111/j.1471-0528.1984.tb04740.x
Abstract
Maternal serum levels of human placental lactogen (hPL), schwangerschaftsprotein 1 (SP1) and pregnancy-associated plasma protein A (PAPP-A) were measured serially throughout pregnancy in 753 women who had a normal pregnancy when recruited during the 2nd trimester. Thirty-three women were delivered of an infant with low birthweight and with phenotypic features of intrauterine growth retardation (IUGR). The predictive value of an abnormal (< 10th centile) hPL result (PVpos) in the identification of IUGR was between 28 and 32%, the sensitivity (36-54%) being greatest at 35 wk gestation. The predictive value of a normal result (PVneg) was 87-96% at various stages of pregnancy, also greatest of 35 wk gestation. For SP1, the sensitivity and predictive values were also greatest at 35 wk gestation (PVpos, 20%; sensitivity, 32%; PVneg, 95%), but for PAPP-A these values were considerably less at all gestations. The trends in levels of hPL, SP1 and PAPP-A observed in individual patients with IUGR were not apparently related to any clinically recognizable feature of the pregnancy or the degree of fetal compromise, irrespective of whether the levels were within or outside the 80% confidence limits of the normal range or whether the levels fell from within the normal range. Maternal hPL measurements are superior in the identification of IUGR in samples obtained at 30-35 wk gestation.This publication has 20 references indexed in Scilit:
- Placental protein measurements in complicated pregnancies. II. Pregnancy‐related hypertensionBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Studies on the concentration of pregnancy-associated plasma protein-a during normal and complicated pregnancyPlacenta, 1981
- MEASUREMENT OF PLACENTAL PROTEIN 5, PLACENTAL LACTOGEN AND PREGNANCY‐SPECIFIC β1 GLYCOPROTEIN IN MID‐TRIMESTER AS A PREDICTOR OF OUTCOME OF PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- TESTS OF FETAL WELLBEING IN THE THIRD TRIMESTER OF PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Assay of a placental protein to determine fetal risk.BMJ, 1980
- Pregnancy‐Specific β‐1 Glycoprotein (SP‐1) in Normal and Abnormal PregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1978
- CIRCULATING LEVELS OF PREGNANCY‐SPECIFIC β1−GLYCOPROTEIN AND HUMAN PLACENTAL LACTOGEN IN THE THIRD TRIMESTER OF PREGNANCY: THEIR RELATIONSHIP TO PARITY, BIRTH WEIGHT, AND PLACENTAL WEIGHTBJOG: An International Journal of Obstetrics and Gynaecology, 1977
- PLASMA LEVELS OF PREGNANCY‐SPECIFIC β1‐GLYCOPROTEIN IN COMPLICATED PREGNANCIESBJOG: An International Journal of Obstetrics and Gynaecology, 1977
- CONCENTRATIONS OF PREGNANCY-SPECIFIC β1-GLYCOPROTEIN IN MATERNAL BLOOD IN NORMAL PREGNANCY AND IN INTRAUTERINE GROWTH RETARDATIONThe Lancet, 1977